InvestorsHub Logo
Followers 185
Posts 2462
Boards Moderated 0
Alias Born 02/10/2017

Re: Ruffieruff post# 1377

Thursday, 06/03/2021 12:13:19 PM

Thursday, June 03, 2021 12:13:19 PM

Post# of 1582
PDS Biotechnology Expands VERSATILE-002 study of PDS0101 and KEYTRUDA® in Advanced Head and Neck Cancer to Include Patients Who Have Failed Prior Treatment with Checkpoint Inhibitors
https://finance.yahoo.com/news/pds-biotechnology-expands-versatile-002-125300514.html


$PDSB

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PDSB News